GSH (-glutamyl-cysteinyl-glycine) is synthesized de novo in two sequential enzymatic ATP-dependent reactions
They postulate the pain felt by patients is out of proportion to the damage seen, the pain is not just because cartilage over the bone gets worn down. They state the thin rim of the cartilage becomes inflamed and sends pain signals to the body
Dose escalation should be individualised based on glycaemic response and tolerability
However, Tirzepatide may be slightly more effective than Semaglutide
All of these fungicides dose-dependently increased MDA levels and decreased GSH content in lung tissue homogenates
Research suggests yes through direct effects on inflammatory pathways, gut health, insulin resistance, and oxidative stress that don't depend on losing weight, which is part of why low-dose "microdosing" can help